Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma.

Blood cells, molecules & diseases - 1 Jan 2000

Fuchs Ota, Provaznikova Dana, Kocova Marcela, Kostecka Arnost, Cvekova Pavla, Neuwirtova Radana, Kobylka Petr, Cermak Jaroslav, Brezinova Jana, Schwarz Jiri, Markova Jana, Salaj Peter, Klamova Hana, Maaloufova Jacqueline, Lemez Petr, Novakova Ludmila, Benesova Katerina

Abstract excerpt

The transcription factor CCAAT/enhancer binding protein (C/EBP)alpha is a myeloid-specific transcription factor which is required for normal myeloid differentiation. C/EBPalpha is encoded by an intronless gene that is 2783 bp long and maps to human chromosome 19q13.1. C/EBPalpha is a member of the basic region leucine zipper (bZIP) class of DNA-binding proteins. The loss of function of C/EBPalpha has leukemogenic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Amino Acid Sequence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CCAAT-Enhancer-Binding Proteins

Share to Leukemia, Myeloid, Acute

Share to Lymphoma, Non-Hodgkin

Share to Multiple Myeloma

Share to Myelodysplastic Syndromes

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 18182175
DOI: 10.1016/j.bcmd.2007.11.005

Genes

EBP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma.PMID 18182175Read ↗

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.Semantic proximity Read ↗

Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias.Semantic proximity Read ↗

C/EBPalpha mutations in acute myeloid leukaemias.Semantic proximity Read ↗

Expression and regulation of C/EBPα in normal myelopoiesis and in malignant transformation.Semantic proximity Read ↗

[Detection of CCAAT/enhancer binding protein alpha gene mutations in acute myeloid leukemia].Semantic proximity Read ↗

A dominant-negative mutant of C/EBPalpha, associated with acute myeloid leukemias, inhibits differentiation of myeloid and erythroid progenitors of man but not mouse.Semantic proximity Read ↗

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA).Semantic proximity Read ↗

[Roles of CEBPA mutation and expression abnormality in acute myeloid leukemia - review].Semantic proximity Read ↗

CCAAT/enhancer binding protein-alpha polymorphisms occur more frequently than mutations in acute myeloid leukemia and exist across all cytogenetic risk groups and leukemia subtypes.Semantic proximity Read ↗

A family harboring a germ-line N-terminal C/EBPalpha mutation and development of acute myeloid leukemia with an additional somatic C-terminal C/EBPalpha mutation.Semantic proximity Read ↗

Multiple ways of C/EBPalpha inhibition in myeloid leukaemia.Semantic proximity Read ↗

Characterization of CEBPA Mutations and Polymorphisms and their Prognostic Relevance in De Novo Acute Myeloid Leukemia Patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.